World First Or Beating The US? China Ups COVID-19 Vaccines Game
Determined To Deliver But Questions Remain
Executive Summary
Touting its coronavirus vaccines as a "global public good", China is quietly preparing for the first general approvals and launches, possibly within weeks, developers say. But who will be first in line to receive them? And at what cost? Distribution and pricing are just some of the unanswered questions.
You may also be interested in...
Coronavirus Update: J&J Pauses COVID-19 Vaccine Trial After Unexplained Illness
J&J becomes the second company to pause a COVID-19 vaccine trial, releasing few details but emphasizing the measure's precautionary nature.
China Nears COVID Vaccine Race 'Victory': CNBG
China is nearing the finish line in the coronavirus vaccines race with just “the last kilometer to go”, and its government is already negotiating with the WHO for potential global supplies.
Medtechs Must Reflect On China Localization Policies As VBP Expands
China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.